Log in

Apyx Medical Stock Forecast, Price & News

-0.03 (-0.60 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $4.95
50-Day Range
MA: $4.88
52-Week Range
Now: $4.95
Volume106,338 shs
Average Volume102,556 shs
Market Capitalization$169.37 million
P/E RatioN/A
Dividend YieldN/A
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.42 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:APYX



Sales & Book Value

Annual Sales$28.15 million
Book Value$2.09 per share


Net Income$-19,710,000.00


Market Cap$169.37 million
Next Earnings Date11/9/2020 (Estimated)
-0.03 (-0.60 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APYX News and Ratings via Email

Sign-up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Apyx Medical (NASDAQ:APYX) Frequently Asked Questions

How has Apyx Medical's stock price been impacted by COVID-19 (Coronavirus)?

Apyx Medical's stock was trading at $5.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, APYX shares have decreased by 2.2% and is now trading at $4.95.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Apyx Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Apyx Medical

When is Apyx Medical's next earnings date?

Apyx Medical is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for Apyx Medical

How were Apyx Medical's earnings last quarter?

Apyx Medical Corp (NASDAQ:APYX) posted its earnings results on Monday, August, 10th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.03. Apyx Medical had a negative net margin of 64.89% and a negative return on equity of 22.98%.
View Apyx Medical's earnings history

What price target have analysts set for APYX?

2 Wall Street analysts have issued 12-month target prices for Apyx Medical's shares. Their forecasts range from $5.00 to $10.00. On average, they expect Apyx Medical's stock price to reach $7.33 in the next twelve months. This suggests a possible upside of 48.1% from the stock's current price.
View analysts' price targets for Apyx Medical

Are investors shorting Apyx Medical?

Apyx Medical saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 515,300 shares, a drop of 13.9% from the August 15th total of 598,600 shares. Based on an average trading volume of 111,400 shares, the short-interest ratio is currently 4.6 days. Approximately 1.7% of the company's shares are sold short.
View Apyx Medical's Short Interest

Who are some of Apyx Medical's key competitors?

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), Store Capital (STOR), Wells Fargo & Company (WFC), Bank of America (BAC), Delta Air Lines (DAL) and Coca-Cola (KO).

Who are Apyx Medical's key executives?

Apyx Medical's management team includes the following people:
  • Mr. Charles D. Goodwin II, Pres, CEO & Director (Age 53)
  • Ms. Tara H. Semb, CFO, Treasurer & Sec. (Age 49)
  • Mr. Moshe Citronowicz, Sr. VP (Age 66)
  • Mr. Todd Hornsby, Exec. VP (Age 43)

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

Who are Apyx Medical's major shareholders?

Apyx Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Taylor Frigon Capital Management LLC (1.63%), Raymond James Financial Services Advisors Inc. (0.80%), Cowen Prime Services LLC (0.70%), ProVise Management Group LLC (0.50%), Goldman Sachs Group Inc. (0.43%) and EAM Investors LLC (0.42%).
View institutional ownership trends for Apyx Medical

Which institutional investors are selling Apyx Medical stock?

APYX stock was sold by a variety of institutional investors in the last quarter, including Cowen Prime Services LLC, Creative Financial Designs Inc. ADV, ProVise Management Group LLC, and AQR Capital Management LLC.
View insider buying and selling activity for Apyx Medical

Which institutional investors are buying Apyx Medical stock?

APYX stock was acquired by a variety of institutional investors in the last quarter, including EAM Investors LLC, Goldman Sachs Group Inc., Taylor Frigon Capital Management LLC, Nuveen Asset Management LLC, Schonfeld Strategic Advisors LLC, Raymond James Financial Services Advisors Inc., California Public Employees Retirement System, and SG Americas Securities LLC.
View insider buying and selling activity for Apyx Medical

How do I buy shares of Apyx Medical?

Shares of APYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $4.95.

How big of a company is Apyx Medical?

Apyx Medical has a market capitalization of $169.37 million and generates $28.15 million in revenue each year. The company earns $-19,710,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. Apyx Medical employs 222 workers across the globe.

What is Apyx Medical's official website?

The official website for Apyx Medical is www.apyxmedical.com.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company can be reached via phone at 727-384-2323 or via email at [email protected]

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.